IDEXX LABORATORIES INC /DE — Director's Dealing 2020

Jun 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2020-05-29

Reporting Person: SZOSTAK M ANNE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-29	Common Stock	M	7722	$63.95	Acquired	7722	Direct
2020-05-29	Common Stock	G	7722	—	Disposed	0	Direct
2020-05-29	Common Stock	G	7722	—	Acquired	7722	Indirect
2020-05-29	Common Stock	S	2980	$306.1191	Disposed	4742	Indirect
2020-05-29	Common Stock	S	3052	$307.0210	Disposed	1690	Indirect
2020-05-29	Common Stock	S	1690	$308.0814	Disposed	0	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-29	Non-Qualified Stock Option (right-to-buy)	$63.95	M	7722	Disposed	2025-05-05	Common Stock (7722)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10217	Indirect

Footnotes

F1: The reporting person is the settlor of the M. Anne Szostak Trust ("Trust"), the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares transferred to the Trust.

F2: The reporting person is the settlor and trustee of the 2020 Szostak IDEXX GRAT (the "GRAT"). The GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.

F3: Represents the weighted average price of the shares sold ranging from a low of $305.53 to a high of $306.52 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F4: Represents the weighted average price of the shares sold ranging from a low of $306.67 to a high of $307.40 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F5: Represents the weighted average price of the shares sold ranging from a low of $307.72 to a high of $308.49 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F6: Grant of option to buy 3,861 shares of IDEXX Laboratories, Inc. common stock that became exercisable in one annual installment on May 6, 2016 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.

F7: Not applicable.